Marco Pieraccioli

800 total citations
20 papers, 539 citations indexed

About

Marco Pieraccioli is a scholar working on Molecular Biology, Cancer Research and Neurology. According to data from OpenAlex, Marco Pieraccioli has authored 20 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Neurology. Recurrent topics in Marco Pieraccioli's work include RNA Research and Splicing (9 papers), RNA modifications and cancer (7 papers) and RNA and protein synthesis mechanisms (4 papers). Marco Pieraccioli is often cited by papers focused on RNA Research and Splicing (9 papers), RNA modifications and cancer (7 papers) and RNA and protein synthesis mechanisms (4 papers). Marco Pieraccioli collaborates with scholars based in Italy, United Kingdom and Japan. Marco Pieraccioli's co-authors include Giuseppe Raschellà, Gerry Melino, Claudio Sette, Sara Nicolai, Pamela Bielli, Cinzia Caggiano, Michal Malewicz, Angela Rachele Soliera, Gloria Manzotti and Giulia Grisendi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Cancer Research.

In The Last Decade

Marco Pieraccioli

20 papers receiving 535 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marco Pieraccioli Italy 15 407 172 94 51 48 20 539
Guolin Chai China 6 377 0.9× 81 0.5× 110 1.2× 39 0.8× 35 0.7× 9 464
Xiaomai Zhou China 4 353 0.9× 110 0.6× 117 1.2× 21 0.4× 38 0.8× 7 469
M M Vleugel Netherlands 5 298 0.7× 251 1.5× 135 1.4× 24 0.5× 40 0.8× 6 444
Hexiu Su China 8 281 0.7× 124 0.7× 107 1.1× 58 1.1× 25 0.5× 11 383
Ami Albihn Sweden 8 323 0.8× 83 0.5× 127 1.4× 67 1.3× 22 0.5× 8 426
Min Soo Kim South Korea 10 254 0.6× 142 0.8× 156 1.7× 17 0.3× 52 1.1× 20 434
Ralitsa R. Madsen United Kingdom 11 280 0.7× 104 0.6× 103 1.1× 21 0.4× 55 1.1× 18 499
Mirtha Laban Singapore 3 486 1.2× 155 0.9× 157 1.7× 16 0.3× 34 0.7× 5 571
Sanika Khare United States 6 171 0.4× 218 1.3× 58 0.6× 31 0.6× 55 1.1× 7 368
Davide Sciuscio Switzerland 11 448 1.1× 252 1.5× 57 0.6× 16 0.3× 95 2.0× 17 657

Countries citing papers authored by Marco Pieraccioli

Since Specialization
Citations

This map shows the geographic impact of Marco Pieraccioli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Pieraccioli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Pieraccioli more than expected).

Fields of papers citing papers by Marco Pieraccioli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Pieraccioli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Pieraccioli. The network helps show where Marco Pieraccioli may publish in the future.

Co-authorship network of co-authors of Marco Pieraccioli

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Pieraccioli. A scholar is included among the top collaborators of Marco Pieraccioli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Pieraccioli. Marco Pieraccioli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Caggiano, Cinzia, Marco Pieraccioli, Eleonora Cesari, et al.. (2024). Transient splicing inhibition causes persistent DNA damage and chemotherapy vulnerability in triple-negative breast cancer. Cell Reports. 43(9). 114751–114751. 2 indexed citations
2.
Pitolli, Consuelo, Alberto Marini, Marco Pieraccioli, et al.. (2023). MYC up-regulation confers vulnerability to dual inhibition of CDK12 and CDK13 in high-risk Group 3 medulloblastoma. Journal of Experimental & Clinical Cancer Research. 42(1). 214–214. 6 indexed citations
3.
Cesari, Eleonora, Alessandra Ciucci, Marco Pieraccioli, et al.. (2023). Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoids. Journal of Experimental & Clinical Cancer Research. 42(1). 126–126. 25 indexed citations
4.
Pieraccioli, Marco, et al.. (2023). CDK12/13 promote splicing of proximal introns by enhancing the interaction between RNA polymerase II and the splicing factor SF3B1. Nucleic Acids Research. 51(11). 5512–5526. 15 indexed citations
5.
Pieraccioli, Marco, Cinzia Caggiano, Chuwei Zhong, et al.. (2022). The transcriptional terminator XRN2 and the RNA-binding protein Sam68 link alternative polyadenylation to cell cycle progression in prostate cancer. Nature Structural & Molecular Biology. 29(11). 1101–1112. 14 indexed citations
6.
Pieraccioli, Marco, et al.. (2022). The DNA/RNA helicase DHX9 contributes to the transcriptional program of the androgen receptor in prostate cancer. Journal of Experimental & Clinical Cancer Research. 41(1). 178–178. 15 indexed citations
7.
Falconi, Giulia, Emiliano Fabiani, Marco Pieraccioli, et al.. (2022). Impairment of FOXM1 expression in mesenchymal cells from patients with myeloid neoplasms, de novo and therapy-related, may compromise their ability to support hematopoiesis. Scientific Reports. 12(1). 21231–21231. 5 indexed citations
8.
Caggiano, Cinzia, Marco Pieraccioli, Consuelo Pitolli, et al.. (2022). The androgen receptor couples promoter recruitment of RNA processing factors to regulation of alternative polyadenylation at the 3' end of transcripts. Nucleic Acids Research. 50(17). 9780–9796. 6 indexed citations
9.
Cesari, Eleonora, Maria Loiarro, Chiara Naro, et al.. (2020). Combinatorial control of Spo11 alternative splicing by modulation of RNA polymerase II dynamics and splicing factor recruitment during meiosis. Cell Death and Disease. 11(4). 240–240. 16 indexed citations
10.
Nicolai, Sara, Marco Pieraccioli, Artem Smirnov, et al.. (2019). ZNF281/Zfp281 is a target of miR‐1 and counteracts muscle differentiation. Molecular Oncology. 14(2). 294–308. 11 indexed citations
11.
Nicolai, Sara, Robert Mahen, Giuseppe Raschellà, et al.. (2019). ZNF281 is recruited on DNA breaks to facilitate DNA repair by non-homologous end joining. Oncogene. 39(4). 754–766. 24 indexed citations
12.
Caggiano, Cinzia, et al.. (2019). c-MYC empowers transcription and productive splicing of the oncogenic splicing factor Sam68 in cancer. Nucleic Acids Research. 47(12). 6160–6171. 30 indexed citations
13.
Bielli, Pamela, Vittoria Pagliarini, Marco Pieraccioli, Cinzia Caggiano, & Claudio Sette. (2019). Splicing Dysregulation as Oncogenic Driver and Passenger Factor in Brain Tumors. Cells. 9(1). 10–10. 23 indexed citations
14.
Bielli, Pamela, Rossano Lattanzio, Marco Pieraccioli, et al.. (2018). The Splicing Factor PTBP1 Promotes Expression of Oncogenic Splice Variants and Predicts Poor Prognosis in Patients with Non–muscle-Invasive Bladder Cancer. Clinical Cancer Research. 24(21). 5422–5432. 41 indexed citations
15.
Pieraccioli, Marco, Sara Nicolai, Consuelo Pitolli, et al.. (2018). ZNF281 inhibits neuronal differentiation and is a prognostic marker for neuroblastoma. Proceedings of the National Academy of Sciences. 115(28). 7356–7361. 38 indexed citations
16.
Grollino, Maria Giuseppa, Giuseppe Raschellà, Eugenia Cordelli, et al.. (2017). Cytotoxicity, genotoxicity and gene expression changes elicited by exposure of human hepatic cells to Ginkgo biloba leaf extract. Food and Chemical Toxicology. 109(Pt 1). 486–496. 24 indexed citations
17.
Nicolai, Sara, Marco Pieraccioli, Angelo Peschiaroli, Gerry Melino, & Giuseppe Raschellà. (2015). Neuroblastoma: oncogenic mechanisms and therapeutic exploitation of necroptosis. Cell Death and Disease. 6(12). e2010–e2010. 47 indexed citations
18.
Pieraccioli, Marco, Sara Nicolai, Joanna Somers, et al.. (2015). ZNF281 contributes to the DNA damage response by controlling the expression of XRCC2 and XRCC4. Oncogene. 35(20). 2592–2601. 38 indexed citations
19.
Pieraccioli, Marco, et al.. (2013). Activation of miR200 by c-Myb depends on ZEB1 expression and miR200 promoter methylation. Cell Cycle. 12(14). 2309–2320. 40 indexed citations
20.
Ferrari‐Amorotti, Giovanna, Valentina Fragliasso, Zelia Prudente, et al.. (2012). Inhibiting Interactions of Lysine Demethylase LSD1 with Snail/Slug Blocks Cancer Cell Invasion. Cancer Research. 73(1). 235–245. 119 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guolin Chai Breakdown of academic impact, for papers by Xiaomai Zhou Breakdown of academic impact, for papers by M M Vleugel Breakdown of academic impact, for papers by Hexiu Su Breakdown of academic impact, for papers by Ami Albihn Breakdown of academic impact, for papers by Min Soo Kim Breakdown of academic impact, for papers by Ralitsa R. Madsen Breakdown of academic impact, for papers by Mirtha Laban Breakdown of academic impact, for papers by Sanika Khare Breakdown of academic impact, for papers by Davide Sciuscio
Rankless by CCL
2026